Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-008329

Chief Operating Officer sold 22,500 shares at $14.48 ($325,800)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GIVEN BRUCE D Chief Operating Officer 2019-02-05 Sale −22,500 $14.48 $325,800 847,856 D
Open-market sales · 22,500 sh · avg $14.48 · $325,800
Loading xslF345X03/doc4.xml…